This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1998 Nov;279(5):46, 50.

doi: 10.1038/scientificamerican1198-46b.

Shutting down a gene. Antisense drug wins approval

G Stix

PMID: 9841380
DOI: 10.1038/scientificamerican1198-46b

Shutting down a gene. Antisense drug wins approval

G Stix. Sci Am. 1998 Nov.

. 1998 Nov;279(5):46, 50.

doi: 10.1038/scientificamerican1198-46b.

Author

G Stix

PMID: 9841380
DOI: 10.1038/scientificamerican1198-46b

No abstract available

PubMed Disclaimer

Similar articles

Antisense drugs progressing through product pipelines.
Traynor K. Traynor K. Am J Health Syst Pharm. 2002 Nov 1;59(21):2046-7. doi: 10.1093/ajhp/59.21.2046. Am J Health Syst Pharm. 2002. PMID: 12434715 No abstract available.
GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
Agrawal S, Tang JY. Agrawal S, et al. Antisense Res Dev. 1992 Winter;2(4):261-6. doi: 10.1089/ard.1992.2.261. Antisense Res Dev. 1992. PMID: 1363378 No abstract available.
Genasense: it ain't over till the fat lady sings.
Stein CA. Stein CA. Oligonucleotides. 2007 Winter;17(4):345-8. doi: 10.1089/oli.2007.9997. Oligonucleotides. 2007. PMID: 17949263 No abstract available.
Antisense and antiviral therapy.
Sherman MI. Sherman MI. Ann N Y Acad Sci. 1990;616:201-4. doi: 10.1111/j.1749-6632.1990.tb17840.x. Ann N Y Acad Sci. 1990. PMID: 2127663 Review. No abstract available.
Antisense therapeutics.
Agrawal S, Zhao Q. Agrawal S, et al. Curr Opin Chem Biol. 1998 Aug;2(4):519-28. doi: 10.1016/s1367-5931(98)80129-4. Curr Opin Chem Biol. 1998. PMID: 9736926 Review.

See all similar articles

Cited by

Crystallographic studies of chemically modified nucleic acids: a backward glance.
Egli M, Pallan PS. Egli M, et al. Chem Biodivers. 2010 Jan;7(1):60-89. doi: 10.1002/cbdv.200900177. Chem Biodivers. 2010. PMID: 20087997 Free PMC article. Review.
Opportunities and challenges for antisense oligonucleotide therapies.
Kuijper EC, Bergsma AJ, Pijnappel WWMP, Aartsma-Rus A. Kuijper EC, et al. J Inherit Metab Dis. 2021 Jan;44(1):72-87. doi: 10.1002/jimd.12251. Epub 2020 Jun 3. J Inherit Metab Dis. 2021. PMID: 32391605 Free PMC article. Review.
Gold Nanoparticle-Mediated Gene Therapy.
Kanu GA, Parambath JBM, Abu Odeh RO, Mohamed AA. Kanu GA, et al. Cancers (Basel). 2022 Oct 31;14(21):5366. doi: 10.3390/cancers14215366. Cancers (Basel). 2022. PMID: 36358785 Free PMC article. Review.
Alginate/poly-L-lysine microparticles for the intestinal delivery of antisense oligonucleotides.
González Ferreiro M, Tillman LG, Hardee G, Bodmeier R. González Ferreiro M, et al. Pharm Res. 2002 Jun;19(6):755-64. doi: 10.1023/a:1016188312399. Pharm Res. 2002. PMID: 12134944
Antisense technology: an overview and prospectus.
Crooke ST, Baker BF, Crooke RM, Liang XH. Crooke ST, et al. Nat Rev Drug Discov. 2021 Jun;20(6):427-453. doi: 10.1038/s41573-021-00162-z. Epub 2021 Mar 24. Nat Rev Drug Discov. 2021. PMID: 33762737 Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Scientific American
Medical
- MedlinePlus Health Information